Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Regine, Baur"'
Publikováno v:
Coronary Artery Disease. 21:286-291
OBJECTIVES The branched-chain fatty acid, valproic acid (VPA), is the most commonly used anti-epileptic drug for treating generalized epilepsy. Recently antiproliferative effects of VPA have been described in human cancer cells, and phase I trials fo
Autor:
Vinzenz Hombach, Cornelia Haug, Andreas Hannekum, Rainer Voisard, Regine Baur, Adolf Gruenert
Publikováno v:
Journal of Cardiovascular Pharmacology. 31:S388-S391
Recent data suggest that endothelin (ET) production is enhanced in coronary atherosclerotic lesions. In several studies, an anti-atherosclerotic effect has been attributed to calcium-channel antagonists. This study aimed to investigate whether ET rel
Autor:
Peter C. Dartsch, Rainer Voisard, Hans Osterhues, Regine Baur, Vinzenz Hombach, Martin Höher, Seitzer U
Publikováno v:
International Journal of Cardiology. 51:15-28
Recent advances in the understanding of the biology of restenosis indicate that it is predominantly caused by a multifactorial stimulation of smooth muscle cell proliferation. The aim of this study was to investigate the in vitro effect of five poten
Publikováno v:
Europe PubMed Central
BACKGROUND Restenosis after angioplasty is generally considered to be caused mainly by an increased proliferation of smooth muscle cells, but recently this theory has been questioned. METHODS Fresh hearts of 25 pigs were obtained and the left anterio
Autor:
Rainer, Voisard, Emini, Ramiz, Regine, Baur, Iris, Gastrock-Balitsch, Heinrich, Siebeneich, Olaf, Frank, Vinzenz, Hombach, Andreas, Hannekum, Bernd, Schumacher
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 16(11)
The effectiveness of human saphenous vein grafting is limited by hyperplasia of the vessel wall. The current paper reports on a pulsed perfused venous human organ culture model (pp-venous HOC-model) with a Windkessel function.Saphenous vein grafts fr
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 13(5)
Low-dose irradiation (LDI) is employed to extend the irradiation area in vascular brachytherapy to minimize the edge effect. Stimulation of adhesion molecule 1 (ICAM-1) is one of many mechanisms important in the early stages of atherosclerosis and re
Autor:
Rainer, Voisard, Regine, Baur, Tina, Herter, Uwe, Krüger, Jürgen, Breul, Lutz, Keller, Vinzenz, Hombach
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 13(2)
Key processes of atherosclerosis and restenosis are triggered and/or modified by the contact of human monocytes (MCs) with the inner layers of the arterial vessel wall. This is the first report on monocyte attack in a perfused renal human organ cultu
Autor:
Regine Baur, Felicitas Fahlisch, Jürgen Gschwendt, Jürgen Braun, Joachim Kamenz, Svenja Zellmann, Fabian Müller, Lutz von Müller, Vinzenz Hombach, Margaratis Kountides, Rainer Voisard
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 7, Iss 1, p 15 (2007)
BMC Cardiovascular Disorders, Vol 7, Iss 1, p 15 (2007)
Background Sirolimus (SRL, Rapamycin) has been used successfully to inhibit restenosis both in drug eluting stents (DES) and after systemic application. The current study reports on the effects of SRL in various human in vitro/ex vivo models and eval
Publikováno v:
BMC Cardiovascular Disorders, Vol 6, Iss 1, p 32 (2006)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Low dose irradiation (LDI) of uninjured segments is the consequence of the suggestion of many authors to extend the irradiation area in vascular brachytherapy to minimize the edge effect. Atherosclerosis is a general disease and the uninju
Publikováno v:
BMC Cardiovascular Disorders, Vol 6, Iss 1, p 14 (2006)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background The significant reduction of angiographic restenosis rates in the ISAR-SWEET study (intracoronary stenting and antithrombotic regimen: is abciximab a superior way to eliminate elevated thrombotic risk in diabetes) raises the question of wh